CBS 2019
CBSMD教育中心
English

充血性心力衰竭

科研文章

荐读文献

Modifiable lifestyle factors and heart failure: A Mendelian randomization study Aliskiren, Enalapril, or Aliskiren and Enalapril in Heart Failure Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes The Management of Atrial Fibrillation in Heart Failure: An Expert Panel Consensus Empagliflozin Increases Cardiac Energy Production in Diabetes - Novel Translational Insights Into the Heart Failure Benefits of SGLT2 Inhibitors Heart Failure and Atrial Fibrillation, Like Fire and Fury Dilated cardiomyopathy: so many cardiomyopathies! Nocturnal thoracic volume overload and post-discharge outcomes in patients hospitalized for acute heart failure Primary Prevention of Heart Failure in Women The prevalence and importance of frailty in heart failure with reduced ejection fraction - an analysis of PARADIGM-HF and ATMOSPHERE

Original Research2021 Jun 12;cvab202.

JOURNAL:Cardiovasc Res. Article Link

AIM2-driven inflammasome activation in heart failure

Z Onódi, M Ruppert, D Kucsera et al. Keywords: canakinumab; cardiomyopathy; drug repurposing; heart failure; inflammation; probenecid

Full Text PDF